| Brand name |
Evusheld
|
|---|---|
| المخاطر |
"Updated dosage recommendations for EVUSHELD (tixagevimab co-packaged with cilgavimab) for pre-exposure prophylaxis against COVID-19 High-risk cardiac patients and the use of EVUSHELD (tixagevimab co packaged with cilgavimab) Risk of cardiovascular events" |
An official government website affiliated with the Government of the Kingdom of Saudi Arabia.
Thu 20 Aug 2026
Beta version
Official Saudi government website domains end with gov.sa
All official websites of government entities in the Kingdom of Saudi Arabia end with.gov.sa.
Official Reliable websites use HTTPS
Ensure the website is using the HTTPS protocol.
Registered with the Digital Government Authority under number:
Comments and Suggestions
For any inquiries or comments about the government services, please fill in the required information.